Loading stock data…
BEAT
$0.88+0.02 (+2.76%)
Market ClosedLast close May 1
HeartBeam, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HeartBeam, Inc. in the Healthcare sector is trading at $0.88. The stock is currently near its 52-week low of $0.54, remaining 40.8% below its 200-day moving average. Technical signals show oversold RSI of 29 and bullish MACD crossover, explaining why BEAT maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Oversold momentum (RSI 29) — potential for technical mean-reversion
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$0.88
Potential Upside
5%
Whystock Fair Value$0.93
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus4 analysts
Buy
Mean target$5.38+509.5%
Range$4.00 – $8.00
Fundamentals
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartB...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$47.85M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.64
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-435.46%
Volume
Today's trading volume
653,306
Recent News
HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold Forever
HeartBeam Inc. (NASDAQ:BEAT) is one of the best NASDAQ growth stocks to buy and hold forever. On April 14, HeartBeam announced the pricing of a $10 million underwritten public offering, consisting of 12,500,000 shares of common stock. The offering is notably led by the company’s first commercial customer, ClearCardio, alongside HeartBeam’s executive leadership, board members, […]
HeartBeam, Inc. Q4 2025 Earnings Call Summary
Moby summary of HeartBeam, Inc.'s Q4 2025 earnings call
HeartBeam Inc (BEAT) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges with ...
HeartBeam Inc (BEAT) reports a $21 million net loss for 2025 but gains momentum with FDA clearance and strategic partnerships.
HeartBeam (BEAT) Q4 2025 Earnings Call Transcript
Brian Humbarger, our new Chief Commercial Officer, will provide an overview of our limited commercial launch. Before we dive into updates since our last call in November, I want to remind everyone about our initial product, the HeartBeam, Inc. system and our platform technology.
BC-Most Active Stocks
Nu Holdings Ltd. 36,506,840 17.06